These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23116346)

  • 1. [Vascular endothelial growth factor in ovarian cancer patients].
    Sedláková I; Tošner J; Kopecký O; Vroblová V; Rezáč A; Skapinec P; Andrýs C
    Ceska Gynekol; 2012 Oct; 77(5):415-20. PubMed ID: 23116346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of basal fibroblast growth factor levels in patients with ovarian tumor.
    Študent V; Andrýs C; Souček O; Špaček J; Tošner J; Sedláková I
    Ceska Gynekol; 2018; 83(3):169-176. PubMed ID: 30764615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
    Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; Boonstra H; Sweep CG
    Cancer; 2001 Jan; 91(2):371-7. PubMed ID: 11180084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.
    Li L; Wang L; Zhang W; Tang B; Zhang J; Song H; Yao D; Tang Y; Chen X; Yang Z; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ
    Anticancer Res; 2004; 24(3b):1973-9. PubMed ID: 15274387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lysophosphatidic acid in ovarian cancer patients].
    Sedlákova I; Vávrová J; Tosner J; Hanousek L
    Ceska Gynekol; 2006 Jul; 71(4):312-7. PubMed ID: 16956044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
    Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of vascular endothelial growth factor in ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Cannon MJ; Pecorelli S; Parham GP
    Eur J Gynaecol Oncol; 1999; 20(3):177-81. PubMed ID: 10410879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.
    Harlozinska A; Sedlaczek P; Kulpa J; Grybos M; Wójcik E; Van Dalen A; Einarsson R
    Anticancer Res; 2004; 24(2C):1149-57. PubMed ID: 15154640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer.
    Hefler LA; Zeillinger R; Grimm C; Sood AK; Cheng WF; Gadducci A; Tempfer CB; Reinthaller A
    Gynecol Oncol; 2006 Nov; 103(2):512-7. PubMed ID: 16750560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic and prognostic values of assay of serum vascular endothelial growth factor in epithelial ovarian cancer].
    Tan X; Shen K; Liu D; Xu X; Lang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Aug; 22(4):352-5. PubMed ID: 12903449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
    Hazelton D; Nicosia RF; Nicosia SV
    Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer.
    Alvarez Secord A; Sayer R; Snyder SA; Broadwater G; Rodriguez GC; Berchuck A; Blackwell K
    Gynecol Oncol; 2004 Jul; 94(1):74-9. PubMed ID: 15262122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in tumor markers, coagulation function and serum VEGF in patients with ovarian cancer and benign ovarian disease.
    Wang J; Zhu M; Zhou X; Wang T; Zhang J
    J BUON; 2020; 25(5):2287-2292. PubMed ID: 33277847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
    Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
    Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer.
    Santin AD; Bellone S; Ravaggi A; Roman J; Smith CV; Pecorelli S; Cannon MJ; Parham GP
    BJOG; 2001 Aug; 108(8):804-8. PubMed ID: 11510703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Ciampi B; Prontera C; Genazzani AR
    Anticancer Res; 1999; 19(2B):1401-5. PubMed ID: 10365113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.